Hexagons on blue gradient background

Peptide Development Drug Delivery Strategies to Enhance Patient Care

Cambridge, MA, United States | 18 September 2024
Overview

Join us for an enlightening session titled Peptide Development Drug Delivery Strategies to Enhance Patient Care, presented by Dr. Andy Lewis, Chief Scientific Officer. This event will explore critical drivers and innovative delivery options for peptide drugs, emphasizing patient-centric approaches.

  • Understand the drivers and delivery options for peptide drugs, putting the patient first 
  • Learn clinical development strategies to switch delivery routes for particular patient populations
  • Learn how it’s possible to phase CMC investment to reduce risk and meet the Target Product Profile 
  • Hear key CMC and clinical learnings from over 14 oral peptide programs evaluating 10 different permeation enhancers

 Don't miss this opportunity to enhance your understanding of cutting-edge peptide development and its impact on patient care.

Complimentary validated parking in the Technology Square Garage

Date/AgendaLocation

Wednesday, September 18th, 2024

Registration: 12:00pm
Lunch, Seminar: 12:30pm - 2:00pm
 

Catalyst Restaurant
300 Technology Square 
Cambridge, MA 0213 

 

 *We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register
Location
Catalyst Restaurant
300 Technology Square
Cambridge, MA, United States

Meet our expert:

We look forward to meeting you at our Seminar Cambridge, MA.

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew